By Patrick Demmer As a pastor and community advocate in Colorado, I have spent more than four decades walking alongside ...

The Health Resources and Services Administration’s definition of who qualifies as a patient under the 340B drug pricing program is too narrowly defined, a federal judge ruled Nov. 7. The lawsuit was ...

Drugmakers are allowed to impose conditions on which pharmacies they dispense discounted drugs to in the 340B program, according to an appellate court. Providers and drugmakers have been at odds for ...

Legislators from both sides of the aisle appear to agree that the controversial 340B drug discount program needs refinement rather than upheaval and broadly welcomed suggestions for greater ...

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big bills. By Ellen Gabler Soon after being diagnosed with metastatic breast ...

Rural hospitals and community health centers are lifelines to the communities they serve. They keep small towns healthy and well, both physically and economically. In New Hampshire alone, hospitals ...

Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...

Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...

The federal agency overseeing the controversial 340B Rebate Model Pilot Program has “vastly underestimated” how much time and money hospitals obligated to participate will spend on reporting burdens, ...

While no government program should be immune from criticism, those who call for reforms should at least understand how the 340B program works. The recent column, “It’s Past Time for Congress to Reform ...